Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @Biopharma_asia
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @Biopharma_asia
-
Prikvačeni tweet
LAST CHANCE TO BOOK YOUR FREE SEAT FOR TODAY’S WEBINAR ON HOW THE BPOG IS MAPPING FUTURE TECHNOLOGY NEEDS FOR REAL TIME RELEASE TESTING.
#biomanufacturing#biopharma#RealTimeReleaseTesting#Biophorum#BPOG#Bioprocessing#Biologics#Biotechnologyhttps://bit.ly/2MoAuo8Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
High-Resolution Optical and Dielectric Methods Monitoring Cells in Bioprocesses -https://biopharma-asia.com/webinars/high-resolution-optical-and-dielectric-methods-monitoring-cells-in-bioprocesses/ …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#Sanofi Announces Positive Topline Results Demonstrated by olipudase alfa#OlipudaseAlfa -https://biopharma-asia.com/sections/sanofi-announces-positive-topline-results-demonstrated-by-olipudase-alfa/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Acquisition of
#Aspen’s Japanese Operations Completed by#Sandoz#Novartis -https://biopharma-asia.com/sections/acquisition-of-aspens-japanese-operations-completed-by-sandoz/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#Lonza Information on Operations Related to the Current#Coronavirus Outbreak#NCoVVirus -https://biopharma-asia.com/sections/lonza-information-on-operations-related-to-the-current-coronavirus-outbreak/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Collaboration Announced by
#CEPI and#GSK to Strengthen the Global Effort to Develop a Vaccine for the 2019-nCoV Virus#NCoVVirus -https://biopharma-asia.com/sections/collaboration-announced-by-cepi-and-gsk-to-strengthen-the-global-effort-to-develop-a-vaccine-for-the-2019-ncov-virus/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#Catalent To Acquire Leading Cell Therapy Company MaSTherCell Global for $315 Million#MaSTherCellGlobal -https://biopharma-asia.com/sections/catalent-to-acquire-leading-cell-therapy-company-masthercell-global-for-315-million/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
CONTINUOUS MANUFACTURING AS A DEFAULT PLATFORM FOR ORAL SOLID DRUG PRODUCTS Presented by Lawrence De Belder, Senior Principal Engineer Continuous Manufacturing at Johnson and Johnson And Bob Lenich, Director of Life Sciences Business at Emerson https://www.brighttalk.com/webcast/10519/375435 ……
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
SAMPLING DEVICES FOR IN-LINE NEAR INFRARED SPECTROSCOPY MONITORING OF POWDER BLEND HOMOGENEITY IN CONTINUOUS MANUFACTURING Anders Sparén, Principal Scientist at AstraZeneca Followed Powder Blend Homogeneity Monitoring with the Viavi MicroNIR PAT-W https://www.brighttalk.com/webcast/10519/376102 ……
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
CONTROL STRATEGY AND A REAL-TIME RELEASE TESTING FROM A DEVELOPMENT LINE TO COMMERCIAL MANUFACTURING PAT analysis performed on the core tablets by NIR spectroscopy to replace the final product testing Tom Van Den Kerkhof Scientist at Johnson & Johnson https://www.brighttalk.com/webcast/10519/376879 ……
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
THE JOURNEY OF IMPLEMENTING ADVANCED PROCESS CONTROL IN THE PHARMACEUTICAL INDUSTRY Presented by Olav Lyngberg, PhD, Sr. Scientific Fellow, Advanced Technology Center of Excellence, Technical Operations, Janssen Pharmaceuticals https://www.brighttalk.com/webcast/10519/379809 ……
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
AFFINITY CHROMATOGRAPHY FOR VACCINES PURIFICATION The journey of establishing the affinity purification platform focusing on main challenges and key results will be presented in the Webinar. Mikkel Nissum, Vaccine R&D Quality Site Lead at GSK Vaccines https://www.brighttalk.com/webcast/10519/381163 ……
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
QUANTIFICATION AND CONTROL OF AMORPHOUS CONTENTS BY RAMAN, APPLICATION AND CASE STUDIES IN PHARMACEUTICAL PROCESSING Michelle Raikes, M.S, Senior Scientist at Boehringer Ingelheim And Dr. Fredrik Nordstrom, Sr Research Fellow at Boehringer Ingelheim https://www.brighttalk.com/webcast/10519/381322 ……
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
ASSESSING THE RISK OF INTERACTION BETWEEN EXTRACTABLES AND LEACHABLE AND THERAPEUTIC PROTEINS Presented by Andrew Teasdale, Senior Principal Scientist Impurity management and External Advocacy at AstraZeneca https://www.brighttalk.com/webcast/10519/381612 ……
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
FULLY UTILIZING CLOSED SYSTEMS IN MODERN BIOPHARMA FACILITIES Presented by Lars Hovmand-Lyster, Senior Engineering Specialist in Novo Nordisk Global Project Office (GPO) Engineering Management Department https://www.brighttalk.com/webcast/10519/381830 ……
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
SINGLE-USE BIOPROCESS PLATFORM FOR VETERINARY VACCINE AND BIOPHARMACEUTICAL PILOT-SCALE PRODUCTION Identify the challenges of integrating vaccine and biopharmaceutical processes Francis Verhoeye, Global Pilot Operations Leader at Zoetis Inc. https://www.brighttalk.com/webcast/10519/381969 ……
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
FROM CONCEPT TO MARKET – UNIQUE APPROACHES IN BIOMANUFACTURING Presented by Dr. Jincai Li, Vice President of WuXi Biologics The presentation will also cover the continuous bioprocessing concept and share WuXi’s efforts on this area https://www.brighttalk.com/webcast/10519/381972 ……
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
NEXT FRONTIER IN SUBVISIBLE PARTICLE ANALYSIS: NEW TOOLS AND OPPORTUNITIES Danny Chou, President Compassion BioSolution, LLC Followed by an Industry Perspective presented by Mark Bumiller, Technology Manager at Particle Sizing Systems, an Entegris https://www.brighttalk.com/webcast/10519/382563 ……
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
STRATEGIES TO OVERCOME LOW ENDOTOXIN RECOVERY USING THE CONVENTIONAL LAL ASSAY Presented by Dr. Ruth Daniels, Senior Scientist – Microbiology Expert at Janssen And Kevin L. Williams, Microbiological Test Development at bioMérieux https://www.brighttalk.com/webcast/10519/383133 ……
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
GLOBAL STERILE TRANSPORTATION AND FORMULATION OF AN ADJUVANT Presented by Charlotte Masy, Project Manager in global support GSK vaccinés Presented by Donald Young, Sr. Product Manager at Thermo Fisher Scientific https://www.brighttalk.com/webcast/10519/383155 ……
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
ESTABLISHING EARLY DEVELOPMENT STRATEGIES FOR THERAPEUTIC PROTEINS Thorsten Lorenz, Head Early Drug Substance Development at Novartis And Sorina Morar-Mitrica, Principal Fellow Sr Drug Product Biologics at Novartis Renee Tobias, Director, Halo Labs https://www.brighttalk.com/webcast/10519/383463 ……
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.